Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.06.23 | Ascendis Pharma: One-Year Data from Phase 3 Trial of TransCon PTH in Adults with Hypoparathyroidism Presented at ENDO 2023 | 390 | GlobeNewswire (Europe) | - Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported for the initial 26-week blinded portion of the... ► Artikel lesen | |
17.06.23 | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023 | 276 | GlobeNewswire (Europe) | -- Mean BMI reduction of 21.0% from baseline observed in 13 patients at six months, showing progression from 16.8% mean BMI reduction at 16 weeks -- -- Phase 3 trial evaluating setmelanotide in acquired... ► Artikel lesen | |
17.06.23 | Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress | 359 | GlobeNewswire (Europe) | New data at week 36 shows atacicept 150 mg resulted in a delta of 43% versus placebo in mean proteinuria reduction in per-protocol analysis and demonstrated statistically significant stabilization... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 3.279 |
EVOTEC | 2.620 |
TUI | 2.064 |
NEL | 1.322 |
BAYER | 1.139 |
PLUG POWER | 1.130 |
NVIDIA | 1.126 |
RHEINMETALL | 1.051 |
AMC ENTERTAINMENT | 1.033 |
DEUTSCHE BANK | 947 |
SIEMENS ENERGY | 927 |
RENK GROUP | 872 |
REDCARE PHARMACY | 725 |
COMMERZBANK | 720 |
HEIDELBERGER DRUCK | 699 |
ALIBABA | 673 |
VOLKSWAGEN | 666 |
E.ON | 611 |
BARRICK GOLD | 607 |
BYD | 586 |
RWE | 580 |
SIEMENS | 561 |
TESLA | 557 |
AIXTRON SE | 554 |
DEUTSCHE LUFTHANSA | 552 |